Table 2.

Best objective tumor response in the total population and by key patient subgroups

	Total population, N = 31	Response by baseline transplantation status and BV status			Response by refractory status to first therapy
		Received BV after unsuccessful ASCT, n = 16	Received BV and ASCT ineligible, n = 8	Received BV before unsuccessful ASCT, n = 7	Refractory to first therapy, n = 11	Not refractory to first therapy, n = 20
ORR (CR + PR), % (95% CI)	58.1 (39.1-75.5)	68.8 (41.3-89.0)	37.5 (8.5-75.5)	57.1(18.4-90.1)	54.5 (23.4-83.3)	60.0 (36.1-80.9)
Response, n (%)
CR	6 (19.4)	3 (18.8)	2 (25.0)	1 (14.3)	3 (27.3)	3 (15.0)
PR	12 (38.7)	8 (50.0)	1 (12.5)	3 (42.9)	3 (27.3)	9 (45.0)
SD	7 (22.6)	3 (18.8)	3 (37.5)	1 (14.3)	4 (36.4)	3 (15.0)
PD	6 (19.4)	2 (12.5)	2 (25.0)	2 (28.6)	1 (9.1)	5 (25.0)